Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies novel biomarker approaches to clinical research, leveraging the latest advancements in science and technology. The Precision for Medicine QuartzBio multiomic data integration and informatics platform enables life sciences companies to discover hidden subgroups of patients who will most benefit from a given therapy, delivering the means for truly personalized medicine. Precision for Medicine is part of Precision Medicine Group, with over 2,000 employees in 35 locations in the US, Canada, and Europe.
For more information, or to learn how to change your cookies preferences, please click here.